scholarly journals A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom

2020 ◽  
Vol 23 (7) ◽  
pp. 751-759 ◽  
Author(s):  
Richard F. Pollock ◽  
Gorden Muduma
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Iron Deficiency ◽  
Iron Deficiency Anemia ◽  
Cost Effectiveness Analysis ◽  
Deficiency Anemia ◽  
Ferric Carboxymaltose ◽  
Patient Level ◽  
The United Kingdom ◽  
Effectiveness Analysis

scholarly journals Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF

2021 ◽  
Author(s):  
Phil McEwan ◽  
Piotr Ponikowski ◽  
Jason A. Davis ◽  
Giuseppe Rosano ◽  
Andrew J.S. Coats ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cost Effectiveness ◽  
Iron Deficiency ◽  
Cost Effectiveness Analysis ◽  
Ferric Carboxymaltose ◽  
Effectiveness Analysis

scholarly journals A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett’s oesophagus in the United Kingdom

2019 ◽  
Vol 35 (5) ◽  
pp. 805-815 ◽  
Author(s):  
Vicki Pollit ◽  
David Graham ◽  
Catherine Leonard ◽  
Alexandra Filby ◽  
Jessica McMaster ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Eradication Therapy ◽  
Cost Effectiveness Analysis ◽  
Barrett’S Oesophagus ◽  
Barrett's Oesophagus ◽  
The United Kingdom ◽  
Effectiveness Analysis

Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom

2013 ◽  
Vol 16 (10) ◽  
pp. 1246-1254 ◽  
Author(s):  
Warren Mark Hart ◽  
Paul Abrams ◽  
Vicki Munro ◽  
Peny Retsa ◽  
Jameel Nazir
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Immediate Release ◽  
Cost Effectiveness Analysis ◽  
The United Kingdom ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document